Oasmia Pharmaceutical AB (OASM) - Financial and Strategic SWOT Analysis Review

Market: Pharmaceuticals and Healthcare

Sweden, 25 pages report, published by GlobalData

Keywords : Oasmia Pharmaceutical AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Report ThumbnailMay-2017

Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company that develops drugs for human and veterinary oncology. The company’s animal health products include doxophos vet and paccal vet. Its human health products include doxophos, paclical, docecal and OAS-19. Oasmia Pharmaceutical’s paclical is a water-soluble formulation of paclitaxel and XR-17 used as anti-cancer substances for treatment of cancers such as breast cancer, lung cancer and ovarian cancer. The company develops products based on in-house research within nanotechnology and company patents. It provides services such as organic synthesis, filling, analysis and freeze-drying, labeling and packaging. The company operates through research facility in Sweden. Oasmia Pharmaceutical is headquartered in Uppsala, Sweden.

Oasmia Pharmaceutical AB Key Recent Developments

Dec 02,2016: Oasmia Pharmaceutical: Interim report for the period May - October 2016
Aug 31,2016: Oasmia Pharmaceutical Appoints Fredrik Gynnerstedt as Chief Financial Officer
Apr 05,2016: Oasmia Pharmaceutical Reports Positive Clinical Study Results for Proprietary XR17 Nanotechnology
Feb 02,2016: Oasmia Pharmaceutical Makes Key Hires; Strengthens Organizational Structure Entering Commercial Phase

This comprehensive SWOT profile of Oasmia Pharmaceutical AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Oasmia Pharmaceutical AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • List of Figures
  • Oasmia Pharmaceutical AB, Performance Chart
  • Oasmia Pharmaceutical AB, Ratio Charts
  • List of Tables
  • Oasmia Pharmaceutical AB, Key Information
  • Oasmia Pharmaceutical AB, Key Ratios
  • Oasmia Pharmaceutical AB, Share Data
  • Oasmia Pharmaceutical AB, Major Products and Services
  • Oasmia Pharmaceutical AB, History
  • Oasmia Pharmaceutical AB, Key Employees
  • Oasmia Pharmaceutical AB, Key Employee Biographies
  • Oasmia Pharmaceutical AB, Key Operational Heads
  • Oasmia Pharmaceutical AB, Other Locations
  • Oasmia Pharmaceutical AB, Subsidiaries
  • Oasmia Pharmaceutical AB, Key Manufacturing facilities
  • Oasmia Pharmaceutical AB, Key Competitors
  • Oasmia Pharmaceutical AB, SWOT Analysis
  • Oasmia Pharmaceutical AB, Ratios based on current share price
  • Oasmia Pharmaceutical AB, Annual Ratios
  • Oasmia Pharmaceutical AB, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • Table of Contents
  • Section 1 - About the Company
  • Oasmia Pharmaceutical AB - Key Information
  • Oasmia Pharmaceutical AB - Overview
  • Oasmia Pharmaceutical AB - Key Employees
  • Oasmia Pharmaceutical AB - Key Employee Biographies
  • Oasmia Pharmaceutical AB - Key Operational Heads
  • Oasmia Pharmaceutical AB - Major Products and Services
  • Oasmia Pharmaceutical AB - History
  • Oasmia Pharmaceutical AB - Company Statement
  • Oasmia Pharmaceutical AB - Locations And Subsidiaries
  • Oasmia Pharmaceutical AB - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • Oasmia Pharmaceutical AB - Business Description
  • Oasmia Pharmaceutical AB - Corporate Strategy
  • Oasmia Pharmaceutical AB - SWOT Analysis
  • SWOT Analysis - Overview
  • Oasmia Pharmaceutical AB - Strengths
  • Oasmia Pharmaceutical AB - Weaknesses
  • Oasmia Pharmaceutical AB - Opportunities
  • Oasmia Pharmaceutical AB - Threats
  • Oasmia Pharmaceutical AB - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • Oasmia Pharmaceutical AB - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company

Please select a license type


Related Products

GlobalDataOasmia Pharmaceutical AB (OASM) - Financial and Strategic SWOT Analysis ReviewProduct ThumbnailOasmia Pharmaceutical AB (OASM) - Financial and Strategic SWOT Analysis Review, Company ReportProduct #: 45209
Global Markets Direct
GBI Research
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved